(Q50512274)

14 March 2018

title

A reappraisal of the medical therapy with steroidogenesis inhibitors in Cushing's syndrome. (English)

1 reference

14 March 2018

author

Iris Crespo

2

1 reference

14 March 2018

Susan M Webb

5

1 reference

14 March 2018

Ignasi Gich

object named as

Ignasi Gich

3

0 references

author name string

Elena Valassi

1

1 reference

14 March 2018

José Rodríguez

4

1 reference

14 March 2018

publication date

1 November 2012

1 reference

14 March 2018

published in

Clinical Endocrinology

1 reference

14 March 2018

volume

77

1 reference

14 March 2018

issue

5

1 reference

14 March 2018

page(s)

735-742

1 reference

14 March 2018

Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04424.X

Pharmacological management of Cushing's syndrome: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04424.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04424.X

Use of ketoconazole in the treatment of Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04424.X

Ketoconazole treatment in Cushing's syndrome: experience in 34 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04424.X

Therapy of Cushing's syndrome with steroid biosynthesis inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04424.X

Ketoconazole revisited: a preoperative or postoperative treatment in Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04424.X

Metyrapone Is Useful Only as Adjunctive Therapy in Cushing's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04424.X

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04424.X

Standards of medical care in diabetes--2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04424.X

Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04424.X

Adipokines and cardiovascular risk in Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04424.X

Medical treatment of Cushing's syndrome: adrenal-blocking drugs and ketaconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04424.X

Incidence of venous thromboembolism in patients with Cushing's syndrome: a multicenter cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04424.X

Comparison of serum cortisol measurement by immunoassay and liquid chromatography-tandem mass spectrometry in patients receiving the 11β-hydroxylase inhibitor metyrapone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04424.X

Pasireotide alone or with cabergoline and ketoconazole in Cushing's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04424.X

10.1111/J.1365-2265.2012.04424.X

21 January 2018

Identifiers

DOI

1 reference

14 March 2018

PubMed ID

22533782

1 reference

14 March 2018